Overview

Weill Medical College of Cornell University is holding a clinical trial on trifocal intraocular lens (IOL) implantation. It is a perspective analysis of intraoperative aberrometry and it is related to the use of eyewear devices. 

Study Information

There is an estimated enrollment of 25 participants. The overall percentage of spectacle independence will be 1 month and 3 months after surgery. A visual quality questionnaire will be given on vision-related functionality and it will be measured from 1 to 4 from a little difficulty, moderate difficulty, quite difficult, impossible to perform.

Inclusion Criteria

All sexes, 18 and older, may participate. Able to consent to study and cataract surgery

• Visually significant cataract
• Potential postoperative visual acuity of 20/25 or better
• Age 18 years or older

Exclusion Criteria

Those not allowed to participate are those with or who have had:

• Ocular pathology contraindicated for trifocal IOLs including but not limited to diabetic retinopathy, age-related macular degeneration or other macular pathology, cornea guttata, corneal scarring, corneal ectasia, glaucoma with visual field loss
• Irregular astigmatism
• Prior corneal refractive surgery

Location

Those interested may participate in this study at Weill Cornell Medicine in New York, New York 10021. Feel free to contact Susan Herder, BA, PA-C or at 646-962-4118 or at herders@med.cornell.edu. 

Sponsors/Collaborators

This clinical trial is sponsored by Weill Medical College of Cornell University and collaborated by Alcon research. Ashley Brissette, MD is the principal investigator.